Copyright Reports & Markets. All rights reserved.

Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue
  • 1.4 Market Analysis by Type
    • 1.4.1 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Screening Biomarker
    • 1.4.3 Diagnosis Biomarker
  • 1.5 Market by Application
    • 1.5.1 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Application: 2020 VS 2026
    • 1.5.2 Diagnostics
    • 1.5.3 Drug Discovery
    • 1.5.4 Personalized Medicine
    • 1.5.5 Others
  • 1.6 Coronavirus Disease 2019 (Covid-19): Prostate Specific Antigen (PSA) Blood Based Biomarker Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Prostate Specific Antigen (PSA) Blood Based Biomarker Industry
      • 1.6.1.1 Prostate Specific Antigen (PSA) Blood Based Biomarker Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Prostate Specific Antigen (PSA) Blood Based Biomarker Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Prostate Specific Antigen (PSA) Blood Based Biomarker Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Global Growth Trends by Regions

  • 2.1 Prostate Specific Antigen (PSA) Blood Based Biomarker Market Perspective (2015-2026)
  • 2.2 Prostate Specific Antigen (PSA) Blood Based Biomarker Growth Trends by Regions
    • 2.2.1 Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Prostate Specific Antigen (PSA) Blood Based Biomarker Historic Market Share by Regions (2015-2020)
    • 2.2.3 Prostate Specific Antigen (PSA) Blood Based Biomarker Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Prostate Specific Antigen (PSA) Blood Based Biomarker Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Prostate Specific Antigen (PSA) Blood Based Biomarker Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Prostate Specific Antigen (PSA) Blood Based Biomarker Players by Market Size
    • 3.1.1 Global Top Prostate Specific Antigen (PSA) Blood Based Biomarker Players by Revenue (2015-2020)
    • 3.1.2 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Concentration Ratio
    • 3.2.1 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue in 2019
  • 3.3 Prostate Specific Antigen (PSA) Blood Based Biomarker Key Players Head office and Area Served
  • 3.4 Key Players Prostate Specific Antigen (PSA) Blood Based Biomarker Product Solution and Service
  • 3.5 Date of Enter into Prostate Specific Antigen (PSA) Blood Based Biomarker Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Historic Market Size by Type (2015-2020)
  • 4.2 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Forecasted Market Size by Type (2021-2026)

5 Prostate Specific Antigen (PSA) Blood Based Biomarker Breakdown Data by Application (2015-2026)

  • 5.1 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2015-2020)
  • 5.2 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size (2015-2020)
  • 6.2 Prostate Specific Antigen (PSA) Blood Based Biomarker Key Players in North America (2019-2020)
  • 6.3 North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2015-2020)
  • 6.4 North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size (2015-2020)
  • 7.2 Prostate Specific Antigen (PSA) Blood Based Biomarker Key Players in Europe (2019-2020)
  • 7.3 Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2015-2020)
  • 7.4 Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2015-2020)

8 China

  • 8.1 China Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size (2015-2020)
  • 8.2 Prostate Specific Antigen (PSA) Blood Based Biomarker Key Players in China (2019-2020)
  • 8.3 China Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2015-2020)
  • 8.4 China Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size (2015-2020)
  • 9.2 Prostate Specific Antigen (PSA) Blood Based Biomarker Key Players in Japan (2019-2020)
  • 9.3 Japan Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2015-2020)
  • 9.4 Japan Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size (2015-2020)
  • 10.2 Prostate Specific Antigen (PSA) Blood Based Biomarker Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2015-2020)

11 India

  • 11.1 India Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size (2015-2020)
  • 11.2 Prostate Specific Antigen (PSA) Blood Based Biomarker Key Players in India (2019-2020)
  • 11.3 India Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2015-2020)
  • 11.4 India Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size (2015-2020)
  • 12.2 Prostate Specific Antigen (PSA) Blood Based Biomarker Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2015-2020)
  • 12.4 Central & South America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 ProteoMediX
    • 13.1.1 ProteoMediX Company Details
    • 13.1.2 ProteoMediX Business Overview and Its Total Revenue
    • 13.1.3 ProteoMediX Prostate Specific Antigen (PSA) Blood Based Biomarker Introduction
    • 13.1.4 ProteoMediX Revenue in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2015-2020))
    • 13.1.5 ProteoMediX Recent Development
  • 13.2 Cleveland Diagnostics
    • 13.2.1 Cleveland Diagnostics Company Details
    • 13.2.2 Cleveland Diagnostics Business Overview and Its Total Revenue
    • 13.2.3 Cleveland Diagnostics Prostate Specific Antigen (PSA) Blood Based Biomarker Introduction
    • 13.2.4 Cleveland Diagnostics Revenue in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2015-2020)
    • 13.2.5 Cleveland Diagnostics Recent Development
  • 13.3 Randox
    • 13.3.1 Randox Company Details
    • 13.3.2 Randox Business Overview and Its Total Revenue
    • 13.3.3 Randox Prostate Specific Antigen (PSA) Blood Based Biomarker Introduction
    • 13.3.4 Randox Revenue in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2015-2020)
    • 13.3.5 Randox Recent Development
  • 13.4 Roche
    • 13.4.1 Roche Company Details
    • 13.4.2 Roche Business Overview and Its Total Revenue
    • 13.4.3 Roche Prostate Specific Antigen (PSA) Blood Based Biomarker Introduction
    • 13.4.4 Roche Revenue in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2015-2020)
    • 13.4.5 Roche Recent Development
  • 13.5 GENFIT
    • 13.5.1 GENFIT Company Details
    • 13.5.2 GENFIT Business Overview and Its Total Revenue
    • 13.5.3 GENFIT Prostate Specific Antigen (PSA) Blood Based Biomarker Introduction
    • 13.5.4 GENFIT Revenue in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2015-2020)
    • 13.5.5 GENFIT Recent Development
  • 13.6 Nutech Cancer Biomarkers
    • 13.6.1 Nutech Cancer Biomarkers Company Details
    • 13.6.2 Nutech Cancer Biomarkers Business Overview and Its Total Revenue
    • 13.6.3 Nutech Cancer Biomarkers Prostate Specific Antigen (PSA) Blood Based Biomarker Introduction
    • 13.6.4 Nutech Cancer Biomarkers Revenue in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2015-2020)
    • 13.6.5 Nutech Cancer Biomarkers Recent Development
  • 13.7 OGT (Sysmex Group)
    • 13.7.1 OGT (Sysmex Group) Company Details
    • 13.7.2 OGT (Sysmex Group) Business Overview and Its Total Revenue
    • 13.7.3 OGT (Sysmex Group) Prostate Specific Antigen (PSA) Blood Based Biomarker Introduction
    • 13.7.4 OGT (Sysmex Group) Revenue in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2015-2020)
    • 13.7.5 OGT (Sysmex Group) Recent Development
  • 13.8 Minomic
    • 13.8.1 Minomic Company Details
    • 13.8.2 Minomic Business Overview and Its Total Revenue
    • 13.8.3 Minomic Prostate Specific Antigen (PSA) Blood Based Biomarker Introduction
    • 13.8.4 Minomic Revenue in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2015-2020)
    • 13.8.5 Minomic Recent Development
  • 13.9 Creative Diagnostics
    • 13.9.1 Creative Diagnostics Company Details
    • 13.9.2 Creative Diagnostics Business Overview and Its Total Revenue
    • 13.9.3 Creative Diagnostics Prostate Specific Antigen (PSA) Blood Based Biomarker Introduction
    • 13.9.4 Creative Diagnostics Revenue in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2015-2020)
    • 13.9.5 Creative Diagnostics Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    This report focuses on the global Prostate Specific Antigen (PSA) Blood Based Biomarker status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Prostate Specific Antigen (PSA) Blood Based Biomarker development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

    The key players covered in this study
    ProteoMediX
    Cleveland Diagnostics
    Randox
    Roche
    GENFIT
    Nutech Cancer Biomarkers
    OGT (Sysmex Group)
    Minomic
    Creative Diagnostics

    Market segment by Type, the product can be split into
    Screening Biomarker
    Diagnosis Biomarker
    Market segment by Application, split into
    Diagnostics
    Drug Discovery
    Personalized Medicine
    Others

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    The study objectives of this report are:
    To analyze global Prostate Specific Antigen (PSA) Blood Based Biomarker status, future forecast, growth opportunity, key market and key players.
    To present the Prostate Specific Antigen (PSA) Blood Based Biomarker development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by type, market and key regions.

    In this study, the years considered to estimate the market size of Prostate Specific Antigen (PSA) Blood Based Biomarker are as follows:
    History Year: 2015-2019
    Base Year: 2019
    Estimated Year: 2020
    Forecast Year 2020 to 2026
    For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

    Buy now